The Correlation between miRNA and Lymph Node Metastasis in Gastric Cancer

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Huang, Kuo Hung ^a,b   Lan, Yuan Tzu ^a,b   Fang, Wen Liang ^a,b   Chen, Jen Hao ^b,c   Lo, Su Shun ^b   Li, Anna Fen Yau ^a,b   Chiou, Shih Hwa ^a,b   Wu, Chew Wun ^a,b   Shyr, Yi Ming ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c EN CHU KONG HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

LET 7A; LET 7E; LET 7F; LET 7G; MICRORNA; MICRORNA 1207 5P; MICRORNA 188 5P; MICRORNA 30A 5P; MICRORNA 451; MICRORNA 497; MIR 96; TUMOR MARKER; UNCLASSIFIED DRUG;

AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MALE; MICROARRAY ANALYSIS; PROSPECTIVE STUDY; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; TUMOR DIFFERENTIATION; UPREGULATION; GENE EXPRESSION PROFILING; GENETICS; MIDDLE AGED; PATHOLOGY; RISK FACTOR; STOMACH NEOPLASMS;

AGED; BIOMARKERS, TUMOR; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS;

EID: 84922357130     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/543163     Document Type: Article

References (21)

1. D. M. Parkin, F. Bray, J. Ferlay, and P. Pisani, "Global cancer statistics, 2002", A Cancer Journal for Clinicians, vol. 55, no. 2, pp. 74-108, 2005.
2. C.-W. Wu, C. A. Hsiung, S.-S. Lo et al., "Nodal dissection for patients with gastric cancer: a randomised controlled trial", Lancet Oncology, vol. 7, no. 4, pp. 309-315, 2006.
3. W.-L. Fang, K.-H. Huang, J.-H. Chen et al., "Comparison of the survival difference between AJCC 6th and 7th editions for gastric cancer patients", World Journal of Surgery, vol. 35, no. 12, pp. 2723-2729, 2011.
4. M. Tsujiura, D. Ichikawa, S. Komatsu et al., "Circulating microRNAs in plasma of patients with gastric cancers", British Journal of Cancer, vol. 102, no. 7, pp. 1174-1179, 2010.
5. H. Zhou, J.-M. Guo, Y.-R. Lou et al., "Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker", Journal of Molecular Medicine, vol. 88, no. 7, pp. 709-717, 2010.
6. X. Li, Y. Zhang, J. Ding, K. Wu, and D. Fan, "Survival prediction of gastric cancer by a seven-microRNA signature", Gut, vol. 59, no. 5, pp. 579-585, 2010.
7. T. Katada, H. Ishiguro, Y. Kuwabara et al., "MicroRNA expression profile in undifferentiated gastric cancer", International Journal of Oncology, vol. 34, no. 2, pp. 537-542, 2009.
8. E. Bandres, N. Bitarte, F. Arias et al., "microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells", Clinical Cancer Research, vol. 15, no. 7, pp. 2281-2290, 2009.
9. J. Tie, Y. Pan, L. Zhao et al., "MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the robo1 receptor", PLoS Genetics, vol. 6, no. 3, Article ID e1000879, 2010.
10. T. Ueda, S. Volinia, H. Okumura et al., "Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis", The Lancet Oncology, vol. 11, no. 2, pp. 136-146, 2010.
11. Z.-L. Chen, X.-H. Zhao, J.-W. Wang et al., "microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin", The Journal of Biological Chemistry, vol. 286, no. 12, pp. 10725-10734, 2011.
12. O. Tchernitsa, A. Kasajima, R. Schäfer et al., "Systematic evaluation of the miRNA-ome and its downstream effects on mRNA expression identifies gastric cancer progression", The Journal of Pathology, vol. 222, no. 3, pp. 310-319, 2010.
13. L. Sobin, M. Gospodarowicz, and C. Wittekind, Eds., TNM Classification of Malignant Tumours, International Union Against Cancer (UICC), John Wiley & Sons, New York, NY, USA, 7th edition, 2009.
14. K. J. Livak and T. D. Schmittgen, "Analysis of relative gene expression data using real-time quantitative PCRand the 2-.... T Method", Methods, vol. 25, no. 4, pp. 402-408, 2001.
15. R. A. Ach, H. Wang, and B. Curry, "Measuring microRNAs: Comparisons of microarray and quantitative PCR measurements, and of different total RNA prepmethods", BMC Biotechnology, vol. 8, article 69, 2008.
16. S. Pradervand, J. Weber, F. Lemoine et al., "Concordance among digital gene expression, microarrays, and qPCR when measuring differential expression of microRNAs", BioTechniques, vol. 48, no. 3, pp. 219-222, 2010.
17. F. C. Moreira, M. Assumpção, I. G. Hamoy et al., "MiRNA expression profile for the human gastric antrum region using ultra-deep sequencing", PLoS ONE, vol. 9, no. 3, Article ID e92300, 2014.
18. W. Wang, H.-S. Luo, and B.-P. Yu, "Expression of NF-.. B and human telomerase reverse transcriptase in gastric cancer and precancerous lesions", World Journal of Gastroenterology, vol. 10, no. 2, pp. 177-181, 2004.
19. L. Chen, M.-H. Lü, D. Zhang et al., "miR-1207-5p and miR-1266 suppress gastric cancer growth and invasion by targeting telomerase reverse transcriptase", Cell Death and Disease, vol. 5, Article ID e1034, 2014.
20. Y. Kang, J. Zhang, P. Sun, and J. Shang, "Circulating cell-free human telomerase reverse transcriptase mRNA in plasma and its potential diagnostic and prognostic value for gastric cancer", International Journal of ClinicalOncology, vol. 18, no. 3, pp. 478-486, 2013.
21. N. Tani, D. Ichikawa, D. Ikoma et al., "Circulating cell-free mRNA in plasma as a tumor marker for patients with primary and recurrent gastric cancer", Anticancer Research, vol. 27, no. 2, pp. 1207-1212, 2007.